CD276 and ovarian carcinoma: Nuclear localization of CD276 in colorectal cancer, high CD276 expression in pancreatic cancer and on tumor-associated endothelial cell in ovarian carcinoma were reported to be a predictive parameter for reduced survival rate12–14.